2024-519661-22-00
Completed
Phase 1
Randomized, crossover, comparative bioavailability study of two Paracetamol-Ibuprofen 25-20 mg/ml oral suspension, administered in single dose to healthy subjects under fasting conditions.
Farmalider S.A.1 site in 1 country24 target enrollmentStarted: February 18, 2025Last updated:
Overview
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- Farmalider S.A.
- Enrollment
- 24
- Locations
- 1
Overview
Brief Summary
No summary available.
Eligibility Criteria
- Ages
- 18 years to 64 years (18-64 Years)
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Carlos Calandria
Scientific
Farmalider S.A.
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Not Applicable
A Phase I Trial on the Relative Bioavailability and Food Effect of HRS-1893 Tablets in Healthy SubjectsNCT07272330Shandong Suncadia Medicine Co., Ltd.38
Completed
Phase 1
A Phase 1 Study Evaluating Relative Bioavailability of Sprinkled Ritlecitinib in Applesauce, Yoghurt, and Strawberry Jam and Evaluating the Effect of Food on the Bioavailability of Ritlecitinib Intact Blend-In Capsule in Healthy Adult Participants.2022-502872-22-00Pfizer Inc.12
Completed
Phase 1
Comparative Bioavailability of Smartech 2% Sodium Diclofenac Topical Solution and PENNSAID 2% Applied to the Knees of Healthy Male and Female SubjectsACTRN12622001391763Avance Clinical Pty Ltd32
Unknown
Phase 1/2
A study to find out the difference in absorption of same dose of drug prepared in 2 different forms, given one followed by the other to the same personCTRI/2009/091/000628Novartis Healthcare Private Limited16
Completed
Phase 1
Absolute Oral Bioavailability of RemimazolamBioavailabilityNCT04113564Paion UK Ltd.14